Author
Listed:
- Abdulrahman Alshammari
(Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia)
- Metab Alharbi
(Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia)
- Abdullah Alghamdi
(Department of Pathology and Laboratory Medicine, Riyadh Security Forces Hospital, Ministry of Interior, Riyadh 11432, Saudi Arabia)
- Saif Ali Alharbi
(Ministry of Health, Riyadh 12613, Saudi Arabia)
- Usman Ali Ashfaq
(Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad 38000, Pakistan)
- Muhammad Tahir ul Qamar
(Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad 38000, Pakistan)
- Asad Ullah
(Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan)
- Muhammad Irfan
(Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL 32611, USA)
- Amjad Khan
(Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan)
- Sajjad Ahmad
(Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan)
Abstract
Antibiotic resistance is a global public health threat and is associated with high mortality due to antibiotics’ inability to treat bacterial infections. Enterobacter xiangfangensis is an emerging antibiotic-resistant bacterial pathogen from the Enterobacter genus and has the ability to acquire resistance to multiple antibiotic classes. Currently, there is no effective vaccine against Enterobacter species. In this study, a chimeric vaccine is designed comprising different epitopes screened from E. xiangfangensis proteomes using immunoinformatic and bioinformatic approaches. In the first phase, six fully sequenced proteomes were investigated by bacterial pan-genome analysis, which revealed that the pathogen consists of 21,996 core proteins, 3785 non-redundant proteins and 18,211 redundant proteins. The non-redundant proteins were considered for the vaccine target prioritization phase where different vaccine filters were applied. By doing so, two proteins; ferrichrome porin (FhuA) and peptidoglycan-associated lipoprotein (Pal) were shortlisted for epitope prediction. Based on properties of antigenicity, allergenicity, water solubility and DRB*0101 binding ability, three epitopes (GPAPTIAAKR, ATKTDTPIEK and RNNGTTAEI) were used in multi-epitope vaccine designing. The designed vaccine construct was analyzed in a docking study with immune cell receptors, which predicted the vaccine’s proper binding with said receptors. Molecular dynamics analysis revealed that the vaccine demonstrated stable binding dynamics, and binding free energy calculations further validated the docking results. In conclusion, these in silico results may help experimentalists in developing a vaccine against E. xiangfangensis in specific and Enterobacter in general.
Suggested Citation
Abdulrahman Alshammari & Metab Alharbi & Abdullah Alghamdi & Saif Ali Alharbi & Usman Ali Ashfaq & Muhammad Tahir ul Qamar & Asad Ullah & Muhammad Irfan & Amjad Khan & Sajjad Ahmad, 2022.
"Computer-Aided Multi-Epitope Vaccine Design against Enterobacter xiangfangensis,"
IJERPH, MDPI, vol. 19(13), pages 1-21, June.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:13:p:7723-:d:846287
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:13:p:7723-:d:846287. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.